Ignite Creation Date:
2025-12-24 @ 12:46 PM
Ignite Modification Date:
2026-05-30 @ 9:24 AM
Study NCT ID:
NCT01887561
Status:
UNKNOWN
Last Update Posted:
2013-06-27
First Post:
2013-04-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dasatinib for Patients Achieving Complete Molecular Response for Cure D-NewS Trial
Sponsor:
Kanto CML Study Group
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Myelogenous Leukemia, Chronic, Chronic Phase | View |
Keywords: